InvestorsHub Logo
Followers 278
Posts 9170
Boards Moderated 1
Alias Born 08/07/2018

Re: None

Saturday, 10/17/2020 10:17:03 AM

Saturday, October 17, 2020 10:17:03 AM

Post# of 46327
$RSPI. Watch this closely .. they have a key Patent Company working with them and they recently went through many of the notes and restructured them in the past month . They have intellectual Patents that are obviously being looked at .
http://respirerx.com/wp-content/uploads/2020/03/NEWCO-Slide-Deck-3-9-2020-PUBLIC.pdf
--
Then go to the Bio's of the executive Mgt Team Tim, Arnold Phd and Jeff, all Pharma, Funding, Patents, Big Money , Company Startups these guys are all about taking it to the next level.
http://respirerx.com/company-management/
--
Besides the Mgt team.. take note of Kathryn McFarlane Pharm MD, she is KEY in and has been in the process of getting RSPI in front of the "Big Boys and Girls" of the pharma world.
--
Kathryn MacFarlane, Pharm.D. – member of Board of Directors

Ms. Macfarlane, a Director since 2014, has over 25 years of experience in the pharmaceutical industry, with expertise in marketing, new product planning, and commercialization. Ms. MacFarlane is the co-founder and an owner and Managing Partner of SmartPharma LLC, a pharmaceutical consulting firm specializing in commercial consulting for emerging pharmaceutical companies, where she has contracted to serve as the Chief Commercial Officer at Agile Therapeutics, Inc. and Sr. Vice President of Commercial Development for Napo Pharmaceuticals. SmartPharma performs market assessments and develops forecasts and commercial plans for pharmaceutical products. Ms. MacFarlane has provided advice to over 75 companies and investors on financing, licensing, and acquisition of drug products and technologies. She is an experienced pharmaceutical executive with over 25 years in the industry, including senior level roles in drug development, marketing, and sales management at Parke-Davis, Pfizer, and Warner Chilcott, where she was the Vice President of Sales, Marketing, and New Product Planning. Ms. MacFarlane played a key role in the launch of several leading brands, most notably Lipitor®, Celexa®, and Loestrin® 24. Ms. MacFarlane earned a B.S. and PharmD from Purdue University and completed a Postdoctoral Fellowship with Rutgers University and Hoffmann-LaRoche. She was named a Distinguished Alumna and was awarded the Eaton Entrepreneur of the Year by the Purdue University School of Pharmacy, where she currently is an Affiliate Faculty member. Ms. MacFarlane is Chairwoman on the Finance Committee for the Board of Directors of INMED Partnerships for Children, and a member of the Executive Committee of the Woodley Park Community Association.

TIME is an ILLUSION
---
TIMING is an actual ART

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RSPI News